Cambridge University Hospitals NHS Foundation Trust

Cambridge, Cambridgeshire CB2 0QQ

1 studies enrolling now · 5 studies all time

What they study most

Cervical Carcinoma, Endometrial Carcinoma, Fallopian Tube Carcinoma, Ovarian Cancer, Ovarian Carcinoma, Primary Biliary Cirrhosis, Primary Peritoneal Carcinoma, Prostate Cancer, Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia

Studies at this site

• ART-Pro: Clinical Trial Evaluating Biparametric MRI and Advanced, Quantitative Diffusion MRI for Detection of Prostate Cancer — Recruiting now
• A Study of CD19 Targeted CAR T Cell Therapy in Adult Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukaemia (ALL) — Running, not enrolling
• Phase 1/2a/3 Evaluation of Adding AL3818 to Standard Platinum-Based Chemotherapy in Subjects With Recurrent or Metastatic Endometrial, Ovarian, Fallopian, Primary Peritoneal or Cervical Carcinoma (AL3818-US-002) — Status unconfirmed
• A Study Of Avelumab Alone Or In Combination With Pegylated Liposomal Doxorubicin Versus Pegylated Liposomal Doxorubicin Alone In Patients With Platinum Resistant/Refractory Ovarian Cancer (JAVELIN Ovarian 200) — Completed
• Study to Assess Safety & Efficacy of GKT137831 in Patients With Primary Biliary Cholangitis Receiving Ursodiol. — Completed